These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25241782)

  • 1. [Phosphorylation status of ASPP2 modulates p53 apoptotic function in oxaliplatin-induced apoptosis of colorectal cancer HCT116 cells].
    Hou Q; Zhao H; Gong W; Zhu Z; Han Y; Chen D; Guo H
    Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):418-23. PubMed ID: 25241782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [ASPP2 inhibits oxaliplatin-induced autophagy and promotes apoptosis of colon cancer cells].
    Wang B; Qiao L; Shi Y; Feng X; Chen D; Guo H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jul; 31(7):898-904. PubMed ID: 26146058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
    Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
    J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Keratin 18 phosphorylation increases autophagy of colorectal cancer HCT116 cells and enhanced its sensitivity to oxaliplatin].
    Yan X; Shi Y; Kou B; Zhu Z; Chai J; Chen D; Guo H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):34-8. PubMed ID: 26728375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of overexpression of apoptosis-stimulating protein 2 of p53 on activation and apoptosis of hepatic stellate cells induced by transforming growth factor-β1 and its mechanism].
    Lin MH; Guo XH; Qiao LX; Xie F; Shi Y
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):890-895. PubMed ID: 31941245
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of Δ40p53 isoform on enhancing the pro-apoptotic function of p53 in tumor cells].
    Wang BS; Zhao HW; Qiao LX; Shan JQ; Hou QS; Chen DX; Guo HL
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):332-338. PubMed ID: 28535648
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
    Liu X; Xu J; Wang S; Yu X; Kou B; Chai M; Zang Y; Chen D
    Int J Oncol; 2017 Oct; 51(4):1291-1299. PubMed ID: 28902369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2).
    Janke K; Brockmeier U; Kuhlmann K; Eisenacher M; Nolde J; Meyer HE; Mairbäurl H; Metzen E
    J Cell Sci; 2013 Jun; 126(Pt 12):2629-40. PubMed ID: 23606740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma.
    Liu K; Jiang T; Ouyang Y; Shi Y; Zang Y; Li N; Lu S; Chen D
    Oncotarget; 2015 Jun; 6(18):16507-16. PubMed ID: 25980493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of ASPP2 by RAS/MAPK pathway is critical for its full pro-apoptotic function.
    Godin-Heymann N; Wang Y; Slee E; Lu X
    PLoS One; 2013; 8(12):e82022. PubMed ID: 24312625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G₀/G₁ to Apoptosis in HCT116 Human Colorectal Carcinoma Cells.
    Jang CH; Moon N; Oh J; Kim JS
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 30987009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative and apoptosis inducing effects of citral via p53 and ROS-induced mitochondrial-mediated apoptosis in human colorectal HCT116 and HT29 cell lines.
    Sheikh BY; Sarker MMR; Kamarudin MNA; Mohan G
    Biomed Pharmacother; 2017 Dec; 96():834-846. PubMed ID: 29078261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of ASPP2/(53BP2L) protein levels by proteasomal degradation modulates p53 apoptotic function.
    Zhu Z; Ramos J; Kampa K; Adimoolam S; Sirisawad M; Yu Z; Chen D; Naumovski L; Lopez CD
    J Biol Chem; 2005 Oct; 280(41):34473-80. PubMed ID: 16091363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
    Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
    Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective autophagosome formation in p53-null colorectal cancer reinforces crocin-induced apoptosis.
    Amin A; Bajbouj K; Koch A; Gandesiri M; Schneider-Stock R
    Int J Mol Sci; 2015 Jan; 16(1):1544-61. PubMed ID: 25584615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines.
    Yang C; Zhou Q; Li M; Tong X; Sun J; Qing Y; Sun L; Yang X; Hu X; Jiang J; Yan X; He L; Wan C
    Sci Rep; 2016 Sep; 6():33078. PubMed ID: 27609465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.
    Liu HF; Hsiao PW; Chao JI
    Chem Biol Interact; 2008 Oct; 176(1):48-57. PubMed ID: 18760266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
    Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
    Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.
    McDermott U; Longley DB; Galligan L; Allen W; Wilson T; Johnston PG
    Cancer Res; 2005 Oct; 65(19):8951-60. PubMed ID: 16204068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
    Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
    PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.